Agios20Pharmaceuticals2C20Inc  (AGIO) - NASDAQGS

  Revenue / EPS Summary *  
 
 Fiscal Quarter 2016
(Fiscal Year)
2015
(Fiscal Year)
2014
(Fiscal Year)
March      
   Revenue $31,281(t) $34,202(t) $8,411(t)
   EPS -0.61 (3/31/2016) -0.13 (3/31/2015) -0.39 (3/31/2014)
   Dividends N/A N/A N/A
June      
   Revenue $6,978(t) $13,219(t) $8,411(t)
   EPS -1.48 (6/30/2016) -0.86 (6/30/2015) -0.55 (6/30/2014)
   Dividends N/A N/A N/A
September      
   Revenue $8,985(t) $5,480(t) $33,900(t)
   EPS -1.63 (9/30/2016) -1.07 (9/30/2015) 0.13 (9/30/2014)
   Dividends N/A N/A N/A
December  (FYE)      
   Revenue $22,648(t) $6,218(t) $14,636(t)
   EPS -1.35 (12/31/2016) -1.09 (12/31/2015) -0.78 (12/31/2014)
   Dividends N/A N/A N/A
Totals      
   Revenue $69,892(t) $59,119(t) $65,358(t)
   EPS -5.07 -3.15 -1.59
   Dividends N/A N/A N/A
Next 3 Years    Previous 3 Years
 
 
©2019, EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.